Intracellular glutathione raising agents for therapeutic treatments
US5766873A · kind A · utility
9Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 31, 1994 |
| Grant date | Jun 16, 1998 |
| Priority date | — |
| Expiry date | Jan 31, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to therapeutic methods for treating diseases associated with tumour necrosis factor-alpha (TNF-.alpha.) induced cell toxicity and/or complement induced cell toxicity, and improved methods for treating diseases whose therapy comprises the administration of n-acetylcysteine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.